Aficamten

ATC C01EB · 4 markets · 13 records

Aficamten 4 markets · 13 records Forms

US 4 records · 4 strengths

20 mgtabletMYQORZO also in CA
15 mgtabletMYQORZO also in CA
10 mgtabletMYQORZO also in CA
5 mgtabletMYQORZO also in CA

CA 4 records · 4 strengths

20 mgtabletMYQORZO also in US
15 mgtabletMYQORZO also in US
10 mgtabletMYQORZO also in US
5 mgtabletMYQORZO also in US

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 MYQORZO

Side-by-side table

Strength / form / release	US	CA	EU
20 mg tablet	MYQORZO	MYQORZO	not recorded
15 mg tablet	MYQORZO	MYQORZO	not recorded
10 mg tablet	MYQORZO	MYQORZO	not recorded
5 mg tablet	MYQORZO	MYQORZO	not recorded
not disclosed unknown	not recorded	not recorded	MYQORZO

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录（未在本表显示）。另有 1 個規格/劑型僅在 EU 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.